Meibomian Gland Dysfunction in Type 2 Diabetic Patients

Table 1

Patient information and results of tear parameters in the diabetic group and nondiabetic group.

Parameters	Diabetic group; (78 eyes)	Nondiabetic group; (108 eyes)	p
Age(yr)	67.05 ± 1.53	67.19 ± 1.72	0.338
Sex ratio (male/female)	16/23	23/31	0.306
Fasting blood glucose (mg/dl)	7.75 ± 1.43	5.80 ± 1.26	<0.001
OSDI	12.79 ± 13.91	13.55 ± 16.42	0.975
TBUT (s)	3.79 ± 2.25	3.99 ± 2.60	0.487
Fluorescein score	1.77 ± 2.49	1.40 ± 2.72	0.076
Schirmer (mm)	5.57 ± 4.70	6.55 ± 5.93	0.431
TMH (mm)	0.19 ± 0.10	0.22 ± 0.14	0.131
NIBUT-1st (s)	6.46 ± 4.13	6.92 ± 4.70	0.849
NIBUT-avg (s)	8.59 ± 4.94	9.53 ± 5.61	0.448
Bulbar hyperaemia	1.47 ± 0.51	2.04 ± 0.54	0.210
Limbal hyperaemia	1.90 ± 0.55	1.61 ± 0.52	0.167